New study finds compounds show promise in blocking STAT3 signaling as treatment for osteosarcoma
Monday, April 11, 2011 - 15:00
in Health & Medicine
A study appearing in the journal Investigational New Drugs and conducted by researchers at Nationwide Children's Hospital, discovered that two new small molecule inhibitors are showing promise in blocking STAT3, a protein linked to the most common malignant bone tumor, osteosarcoma. These small molecule inhibitors one derived from a portion of the turmeric spice may serve as a new, non-toxic treatment for these deadly tumors.